Enoxaparin 0.3 mg/kg IV supplement for patients transitioning to PCI after subcutaneous enoxaparin therapy for NSTE ACS: A subgroup analysis from the SYNERGY trial

Marc Cohen, Glenn Levine, Karen Pieper, Lan Lan, Elliott Antman, Philip Aylward, Harvey White, Neal Kleiman, Robert Califf, Kenneth Mahaffey

    Research output: Contribution to journalArticlepeer-review

    16 Citations (Scopus)

    Fingerprint

    Dive into the research topics of 'Enoxaparin 0.3 mg/kg IV supplement for patients transitioning to PCI after subcutaneous enoxaparin therapy for NSTE ACS: A subgroup analysis from the SYNERGY trial'. Together they form a unique fingerprint.

    Medicine & Life Sciences